(9R)-9-chloro-11-17-dihydroxy-17-(2-hydroxy-1-oxoethyl)-10-13-16-trimethyl-6-7-8-11-12-14-15-16-octahydrocyclopenta[a]phenanthren-3-one and Eczema

To observe the clinical efficacy of nasal vestibule eczema by using beclomethasone dipropionate in combination with He-Ne laser therapy.. The 200 cases of nasal vestibule eczema patients were randomly divided into treatment and control groups. The control group received the rub beclomethasone dipropionate cream treatment one time per day. The treatment group supplemented with He-Ne laser irradiation treatment on the basis of the control group on the same treatment, alsoone time per day. Then the results were analyzed.. The total effective rate was 100.0% in treatment group, while 75.0% in the control group. The difference between the two groups was statistically significant (P < 0.05).. Beclomethasone dipropionate cream combined with He-Ne laser irradiation therapy on nasal vestibule eczema is significant, and easily to operate, with significant anti-inflammatory, anti-itch, analgesic effects.

Topics: Administration, Inhalation; Anti-Inflammatory Agents; Beclomethasone; Combined Modality Therapy; Double-Blind Method; Eczema; Glucocorticoids; Humans; Laser Therapy; Male

Beclomethasone dipropionate (BDP) was used in a trial to assess the effectiveness of twice daily compared with four times daily dosage in the control of asthma. Prior to the introduction of BDP all but one of the patients were dependent on oral steroids in addition to other therapeutic regimes for adequate control of their asthma. A cross-over design was used with patients randomly allocated to either a twice daily or four times daily initial BDP regime. The trial continued for thirty-two weeks, with patients changing their dose regime at the end of each eight week period. Maintenance steroids were eliminated in all but two of the patients. According to all the criteria used in assessing control of asthma, there were no significant differences between the two regimes, indicating that both were equally effective. Compliance was better with the twice daily regime, and most patients preferred it.

Topics: Adolescent; Adult; Aerosols; Asthma; Beclomethasone; Child; Child Development; Eczema; Female; Humans; Male; Middle Aged; Patient Compliance; Rhinitis, Allergic, Seasonal; Statistics as Topic; Steroids

Topics: Administration, Topical; Adolescent; Adrenal Glands; Adrenocorticotropic Hormone; Aerosols; Anti-Inflammatory Agents; Asthma; Beclomethasone; Body Height; Child; Child, Preschool; Clinical Trials as Topic; Eczema; Female; Growth; Humans; Hydrocortisone; Male; Prednisone; Rhinitis; Rhinitis, Allergic, Seasonal; Time Factors

Topics: Administration, Topical; Adolescent; Adrenal Glands; Adult; Anti-Inflammatory Agents; Beclomethasone; Clinical Trials as Topic; Dermatitis; Dermatitis, Contact; Dermatitis, Exfoliative; Dermatitis, Seborrheic; Eczema; Female; Humans; Hydrocortisone; Male; Methylprednisolone; Middle Aged; Propionates; Time Factors

Topics: Administration, Topical; Adolescent; Adrenal Cortex Hormones; Adrenocorticotropic Hormone; Aerosols; Anti-Inflammatory Agents; Asthma; Beclomethasone; Child; Clinical Trials as Topic; Eczema; Female; Humans; Hydrocortisone; Male; Methylprednisolone; Recurrence; Rhinitis, Allergic, Seasonal; Spirometry

Forty-two chronic asthmatic children, including 10 with associated eczema, were examined for lenticular complications. The children had received oral corticosteroids for a minimum of 3 years. Twelve were treated with beclomethasone inhalant therapy, and the children with eczema had had topical corticosteroids. Only one child was found to have cataracts commensurate with corticosteroid therapy. Possible reasons for the low incidence of cataracts in this study are discussed.

Topics: Adolescent; Adrenal Cortex Hormones; Asthma; Beclomethasone; Cataract; Child; Child, Preschool; Cromolyn Sodium; Drug Therapy, Combination; Eczema; Female; Humans; Male; Prednisone

Topics: Aged; Beclomethasone; Eczema; Female; Humans; Male; Middle Aged; Myxedema; Thyroxine